WO1998028367A1 - Method of suspending insoluble calcium salts in protein compositon - Google Patents
Method of suspending insoluble calcium salts in protein compositon Download PDFInfo
- Publication number
- WO1998028367A1 WO1998028367A1 PCT/US1997/023785 US9723785W WO9828367A1 WO 1998028367 A1 WO1998028367 A1 WO 1998028367A1 US 9723785 W US9723785 W US 9723785W WO 9828367 A1 WO9828367 A1 WO 9828367A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- calcium
- protein
- process according
- mixture
- milk
- Prior art date
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 126
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 126
- 159000000007 calcium salts Chemical class 0.000 title claims abstract description 71
- 238000000034 method Methods 0.000 title claims abstract description 70
- 239000000203 mixture Substances 0.000 claims abstract description 91
- 239000013049 sediment Substances 0.000 claims abstract description 55
- 230000008569 process Effects 0.000 claims abstract description 54
- 239000000725 suspension Substances 0.000 claims abstract description 42
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 41
- 238000001035 drying Methods 0.000 claims abstract description 16
- 239000000843 powder Substances 0.000 claims abstract description 11
- 238000002156 mixing Methods 0.000 claims abstract 12
- 235000018102 proteins Nutrition 0.000 claims description 123
- 239000011575 calcium Substances 0.000 claims description 116
- 229910052791 calcium Inorganic materials 0.000 claims description 114
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 113
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 88
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 62
- 108010011756 Milk Proteins Proteins 0.000 claims description 47
- 102000014171 Milk Proteins Human genes 0.000 claims description 46
- 235000021239 milk protein Nutrition 0.000 claims description 45
- 108010076119 Caseins Proteins 0.000 claims description 41
- 102000011632 Caseins Human genes 0.000 claims description 41
- 239000012141 concentrate Substances 0.000 claims description 36
- 235000013336 milk Nutrition 0.000 claims description 35
- 239000008267 milk Substances 0.000 claims description 35
- 210000004080 milk Anatomy 0.000 claims description 35
- 235000010216 calcium carbonate Nutrition 0.000 claims description 33
- 108010033929 calcium caseinate Proteins 0.000 claims description 30
- 239000004615 ingredient Substances 0.000 claims description 30
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 claims description 29
- 239000001506 calcium phosphate Substances 0.000 claims description 28
- 239000005018 casein Substances 0.000 claims description 28
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 28
- 235000021240 caseins Nutrition 0.000 claims description 28
- 229910000389 calcium phosphate Inorganic materials 0.000 claims description 23
- 235000011010 calcium phosphates Nutrition 0.000 claims description 23
- 239000002253 acid Substances 0.000 claims description 21
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 18
- 108010073771 Soybean Proteins Proteins 0.000 claims description 15
- 229940001941 soy protein Drugs 0.000 claims description 15
- 229940080237 sodium caseinate Drugs 0.000 claims description 13
- 238000010438 heat treatment Methods 0.000 claims description 9
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 claims description 7
- 239000001354 calcium citrate Substances 0.000 claims description 6
- 235000013337 tricalcium citrate Nutrition 0.000 claims description 6
- 235000019731 tricalcium phosphate Nutrition 0.000 claims description 6
- 235000008733 Citrus aurantifolia Nutrition 0.000 claims description 5
- 235000011941 Tilia x europaea Nutrition 0.000 claims description 5
- 239000004571 lime Substances 0.000 claims description 5
- 229910000391 tricalcium phosphate Inorganic materials 0.000 claims description 5
- 229940078499 tricalcium phosphate Drugs 0.000 claims description 5
- 239000007900 aqueous suspension Substances 0.000 claims description 4
- 239000012460 protein solution Substances 0.000 claims 3
- 239000011363 dried mixture Substances 0.000 claims 2
- 239000011874 heated mixture Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 1
- 230000009286 beneficial effect Effects 0.000 abstract description 9
- 229960005069 calcium Drugs 0.000 description 110
- 235000001465 calcium Nutrition 0.000 description 110
- 239000002245 particle Substances 0.000 description 31
- 235000013305 food Nutrition 0.000 description 30
- 239000000047 product Substances 0.000 description 30
- 229940071162 caseinate Drugs 0.000 description 22
- 238000009472 formulation Methods 0.000 description 20
- 238000002360 preparation method Methods 0.000 description 18
- 150000003839 salts Chemical class 0.000 description 13
- 229940069978 calcium supplement Drugs 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 108010046377 Whey Proteins Proteins 0.000 description 9
- 238000012545 processing Methods 0.000 description 9
- 238000003860 storage Methods 0.000 description 9
- 238000005516 engineering process Methods 0.000 description 8
- 235000021067 refined food Nutrition 0.000 description 8
- 239000000306 component Substances 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000002244 precipitate Substances 0.000 description 7
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- 239000003513 alkali Substances 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 239000003795 chemical substances by application Substances 0.000 description 6
- 239000003925 fat Substances 0.000 description 6
- 235000019197 fats Nutrition 0.000 description 6
- 235000019624 protein content Nutrition 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 229910019142 PO4 Inorganic materials 0.000 description 5
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 5
- 239000000920 calcium hydroxide Substances 0.000 description 5
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 5
- 235000013339 cereals Nutrition 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 description 5
- 239000011707 mineral Substances 0.000 description 5
- 235000010755 mineral Nutrition 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- 235000021317 phosphate Nutrition 0.000 description 5
- 235000021119 whey protein Nutrition 0.000 description 5
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 4
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 4
- 239000005862 Whey Substances 0.000 description 4
- 102000007544 Whey Proteins Human genes 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 239000001110 calcium chloride Substances 0.000 description 4
- 229910001628 calcium chloride Inorganic materials 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000084 colloidal system Substances 0.000 description 4
- 235000013365 dairy product Nutrition 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 235000013861 fat-free Nutrition 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
- 239000010452 phosphate Substances 0.000 description 4
- 235000020183 skimmed milk Nutrition 0.000 description 4
- 238000000108 ultra-filtration Methods 0.000 description 4
- 238000000576 coating method Methods 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 239000005417 food ingredient Substances 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 235000008476 powdered milk Nutrition 0.000 description 3
- 235000004252 protein component Nutrition 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- 238000011282 treatment Methods 0.000 description 3
- 241000251468 Actinopterygii Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical group C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 238000010306 acid treatment Methods 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 229910021529 ammonia Inorganic materials 0.000 description 2
- 235000004251 balanced diet Nutrition 0.000 description 2
- 230000037182 bone density Effects 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- 235000013351 cheese Nutrition 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000021245 dietary protein Nutrition 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 235000019688 fish Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000000227 grinding Methods 0.000 description 2
- 150000004679 hydroxides Chemical class 0.000 description 2
- 239000012669 liquid formulation Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 229940029985 mineral supplement Drugs 0.000 description 2
- 235000020786 mineral supplement Nutrition 0.000 description 2
- 239000000178 monomer Substances 0.000 description 2
- 230000003472 neutralizing effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000008188 pellet Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 101800000263 Acidic protein Proteins 0.000 description 1
- WPWUFUBLGADILS-WDSKDSINSA-N Ala-Pro Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(O)=O WPWUFUBLGADILS-WDSKDSINSA-N 0.000 description 1
- BHPQYMZQTOCNFJ-UHFFFAOYSA-N Calcium cation Chemical compound [Ca+2] BHPQYMZQTOCNFJ-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical class [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical class [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- 102000015781 Dietary Proteins Human genes 0.000 description 1
- 108010010256 Dietary Proteins Proteins 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 208000000913 Kidney Calculi Diseases 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- 206010029148 Nephrolithiasis Diseases 0.000 description 1
- 239000006057 Non-nutritive feed additive Substances 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 108010058846 Ovalbumin Proteins 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 230000002776 aggregation Effects 0.000 description 1
- 238000004220 aggregation Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 108010087924 alanylproline Proteins 0.000 description 1
- 235000019728 animal nutrition Nutrition 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 229920001586 anionic polysaccharide Polymers 0.000 description 1
- 150000004836 anionic polysaccharides Chemical class 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000008468 bone growth Effects 0.000 description 1
- 230000003139 buffering effect Effects 0.000 description 1
- 229940043430 calcium compound Drugs 0.000 description 1
- 150000001674 calcium compounds Chemical class 0.000 description 1
- 229910001424 calcium ion Inorganic materials 0.000 description 1
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 description 1
- 239000001527 calcium lactate Substances 0.000 description 1
- 235000011086 calcium lactate Nutrition 0.000 description 1
- 229960002401 calcium lactate Drugs 0.000 description 1
- 239000001362 calcium malate Substances 0.000 description 1
- OLOZVPHKXALCRI-UHFFFAOYSA-L calcium malate Chemical compound [Ca+2].[O-]C(=O)C(O)CC([O-])=O OLOZVPHKXALCRI-UHFFFAOYSA-L 0.000 description 1
- 229940016114 calcium malate Drugs 0.000 description 1
- 235000011038 calcium malates Nutrition 0.000 description 1
- 235000021375 calcium rich food Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000009920 chelation Effects 0.000 description 1
- 238000012993 chemical processing Methods 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 235000014156 coffee whiteners Nutrition 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 235000015142 cultured sour cream Nutrition 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 239000002270 dispersing agent Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000009144 enzymatic modification Effects 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000005428 food component Substances 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 239000006194 liquid suspension Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 208000012866 low blood pressure Diseases 0.000 description 1
- 235000004213 low-fat Nutrition 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 235000020991 processed meat Nutrition 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 235000020122 reconstituted milk Nutrition 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 239000011833 salt mixture Substances 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000021055 solid food Nutrition 0.000 description 1
- 239000002195 soluble material Substances 0.000 description 1
- 229940071440 soy protein isolate Drugs 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 235000008939 whole milk Nutrition 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/385—Concentrates of non-alcoholic beverages
- A23L2/39—Dry compositions
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/04—Animal proteins
- A23J3/08—Dairy proteins
- A23J3/10—Casein
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
- A23J3/00—Working-up of proteins for foodstuffs
- A23J3/14—Vegetable proteins
- A23J3/16—Vegetable proteins from soybean
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/40—Shaping or working of foodstuffs characterised by the products free-flowing powder or instant powder, i.e. powder which is reconstituted rapidly when liquid is added
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K13/00—Use of mixtures of ingredients not covered by one single of the preceding main groups, each of these compounds being essential
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
- C08K3/00—Use of inorganic substances as compounding ingredients
- C08K3/18—Oxygen-containing compounds, e.g. metal carbonyls
- C08K3/24—Acids; Salts thereof
Definitions
- This invention relates generally to the treatment of insoluble calcium salts in protein compositions to produce a dry powder that can be reconstituted in water or other media to produce a suspension of the insoluble calcium salts with the beneficial feature that the treated calcium salts do not form a sediment or otherwise separate from the prepared suspensions.
- Calcium as Food Supplements Calcium is a beneficial component of animal nutrition. In human nutrition, calcium should be a part of the diet from birth to death. From birth to young adulthood, the calcium consumed as part of the diet is utilized for bone growth, bone density, tooth enamel, and a number of important cellular activities. For the teenage years through mature adulthood, calcium is used to maintain bone density and avoid osteoporosis. Maintenance of a routine, daily intake of bioavailable calcium also contributes to low blood pressure and reducing the incidence of kidney stones.
- Calcium supplements are, in general, calcium salts that are either soluble or insoluble in water.
- the soluble calcium salts for instance calcium chloride, calcium lactate, calcium malate, and, to some extent, calcium citrate
- the insoluble calcium salts, calcium carbonate and calcium phosphate have low calcium reactivities and do not have undesirable reactions with other processed food components.
- insoluble calcium salts have a chalky or gritty texture and they separate out of food formulations instead of remaining homogeneously dispersed in the food.
- U.S. Patent 5,205,493 describes a method for preparing calcium carbonate by a series of grinding steps and particle selection processes in order to produce a uniform, small particle size.
- J. Bleeck and A. E. Hodel describe a method for grinding and then using air classification techniques to separate and select small particles of the insoluble salt.
- small particle sizes can be obtained, it is difficult to obtain high yields of particles that are less than 1 micron.
- particles that are 1 micron in diameter still settle out of liquids fairly rapidly because of the lack of interaction with other components and because of a relatively high particle density.
- the second way of suspending insoluble calcium salts in food preparations, especially liquids, is to use gums and thickeners in order to increase the viscosity of the composition.
- This is exemplified by U.S. Patent 4,701,329 which describes adding a finely divided calcium compound into milk containing carrageenan and guar gum.
- the finely divided calcium salts will still settle out, but at a slower rate than in less viscous preparations.
- the third way of keeping insoluble calcium salts from settling or packing at the bottom of liquid suspensions is through special preparations involving physical barriers and chemical reactions.
- Hirotsuka et al described the preparation of calcium-containing lipozomes made using soluble calcium salts coated with a membrane of soy lecithin. This invention would release protein reactive calcium ions if heated.
- U.S. Patent 5,317,053 described a method for maintaining a stable, high solids suspension of calcium carbonate using a copolymer of acrylic acid and a sulfonated vinyl monomer. These latter compositions are not allowed in foods.
- Rosenberg at el Journal of Dispersion Sciences and Technology. 1989, 241-250
- Highly concentrated calcium carbonate suspensions can be maintained at a workable consistency using this invention, but, in foods, the calcium supplements are not concentrated which limits the utility of the invention for food compositions.
- Lin and Cho U.S.
- patent 4,642,2308 described a process for keeping calcium phosphate from settling out of water suspensions by first making a hydrated gel (no particles) of calcium phosphate, then adding soy protein to the hydrated gel, and finally drying the calcium phosphate supplemented soy protein. The dried product made via this process can then be redispersed in a liquid food with improved suspension of the calcium supplement.
- Soy protein containing the calcium phosphate had a calcium content ranging from 1.5% to 5.0% by weight of the protein. It would be desirable to utilize readily available commercial raw materials, to not have to prepare and wash the specialized calcium phosphate gel, and to extend the calcium content or the calcium to protein ratio to much higher levels suitable for use as a supplement in other foods.
- proteins are used for two main reasons. First, they are used to provide desirable functional or sensory characteristics, and these include: emulsion stability, texture, appearance, mouthfeel, flavor, and physical stability during production, storage, and preparation for consumption. Second, proteins may be included in processed food formulations for nutritional purposes. That is, approximately 50 grams of high quality dietary protein should be consumed daily as part of a balanced diet.
- Foods that are high in protein are used by ingredient processors to prepare protein concentrates and protein isolates.
- These protein-containing ingredients may be from 25 to 95% protein, on a dry basis, and they may, for instance, be in the form of: milk and dried milk, milk protein concentrates and dried milk concentrates, milk protein fractions such as casein and whey, soy protein concentrates and soy isolates, egg albumin, meat and plasma extracts or concentrates, nut flour and protein concentrates derived therefrom, fish and fish protein concentrates, and a number of others. Aside from milk, most of these protein sources are not good calcium sources.
- Some proteins can be isolated from foods by precipitating the proteins with an acid treatment.
- the preparation of soy protein isolates and the preparation of milk proteins, especially casein, typify this kind of isolation technique.
- the proteins are precipitated at or near the isoelectric point of the protein, usually around pH 4.5.
- These acid precipitates are washed to remove oils, carbohydrates, and other soluble materials and then they are either dried or they can be neutralized with a variety of food grade alkali agents in order to produce highly functional food ingredients. If the alkali used is calcium hydroxide, Ca(OH) 2 , then a calcium caseinate or a calcium soy isolate, for example, can be produced.
- These neutralized calcium-containing proteins are also good sources of bioavailable calcium, but there is a limit to the amount of calcium that can be provided per gram of protein, with this limit dictated by the acid treatment and the buffering capacity of the acidic protein produced as a precipitate.
- the calcium of milk is provided by a natural colloidal suspension of calcium phosphate in a complex structure involving aggregates of casein or caseinates.
- the calcium to protein ratio in milk is approximately 35 mg of calcium per gram of protein, or 3.5 grams of calcium per 100 grams of protein.
- This colloidal suspension is solubilized and removed during the preparation of precipitated acid casein.
- acid casein is re-neutralized with lime, Ca(OH) 2
- the maximum level of calcium that can be achieved is approximately 1.4 to 1.5 grams of calcium per 100 grams of protein.
- Calcium caseinates are less soluble than caseinates made by neutralizing acid casein with a monovalent base such as sodium hydroxide,
- calcium caseinates do not have the same functional attributes of soluble sodium caseinate. That is, calcium caseinates do not have the body, mouthfeel, viscosity, adhesive characteristic, or emulsion and foam stabilization properties of the more soluble sodium caseinate. It would be highly desirable to prepare calcium caseinates that have a high level of calcium and that also have the functional attributes of the more soluble sodium caseinate.
- Milk protein coprecipitate is an insoluble form of both the casein and the whey proteins from milk.
- the coprecipitate derives its name from the fact that the usually soluble whey proteins are collected as a precipitate along with casein under conditions in which the coprecipitate is made.
- the products of this invention contain higher levels of calcium than heretofore obtained by any process.
- the calcium-containing proteins of this invention are unlike calcium-containing proteins of disclosed art in that the new products have solubility, viscosity, and emulsion stability characteristics similar to sodium forms of proteins, yet they have the opacity characteristic of calcium forms of the protein. Readily available food ingredients and standard processing equipment are used.
- the high calcium proteins are easily dispersed in food compositions and they remain homogeneously dispersed throughout processing.
- milk proteins, milk protein concentrates, milk protein coprecipitates, and soy isolates can be used in the preparation of calcium supplements that do not sediment in processed foods, those skilled in the art will recognize that other proteins and protein combinations could also be used.
- the composition uses inexpensive ingredients that are readily available.
- the processing employs equipment currently used for ingredient manufacturing. It has been found that by drying a suspension of an insoluble calcium salt in the presence of a protein, the insoluble salt is converted, without dissolving and without apparent chemical conversion, to a form especially useful as a calcium supplement in processed foods where calcium salts, in general, sediment or create instability. In these foods, the modified calcium salt of this invention remains dispersed and suspended for a much longer time than the unmodified calcium salt.
- the protein and calcium composition also has among its desirable attributes; that it does not precipitate proteins, it does not form a sediment layer, it does not have a chalky or powdery mouthfeel, it provides opacity or a white appearance, and it is stable to heat treatments.
- the new calcium ingredients can be used to supplement liquids, semi-solids, and solid foods, and the technique can be used to keep pigments of insoluble calcium salts suspended for consistent, even coatings on finished goods.
- the two components of this new composition are a protein and a calcium-containing salt. These are mixed together and the mixture is dried to produce a calcium-containing protein ingredient with the enhanced calcium suspension properties.
- Milk, skim milk, egg white, extracts from grains, etc. may be used in their most convenient, economic form.
- Dried protein preparations are suspended or dissolved in water or other liquid media.
- Insoluble proteins such as acid casein or soy are rendered at least partially soluble by the addition of alkali. Na, K, Ca, Mg, oxides or hydroxides as well as ammonia, alkaline phosphates, citrates, or carbonates are some of the alkaline agents that can be used to adjust the pH above the isoelectric pH.
- Heat treatment, chelation, and chemical or enzymatic modifications may also be applied to produce a suitable protein component. Reconstitution of a dried form of the protein ingredient is not required.
- Casein is the protein that is precipitated from milk by adjusting the pH of the milk to the isoelectric point of the milk protein.
- the precipitated protein is typically washed to remove fat, carbohydrate, and soluble minerals and protein.
- the precipitated casein can be dried and stored for later use or the casein can be converted from the hydrated, acid curd to another form by treatment with alkali, heat, salts, enzymes, or other processing aids.
- Precipitated or acid casein is converted to a caseinate, a more soluble, functional form, by treatment with alkaline agents.
- Typical alkalis include Na, K, Ca, Mg, or other oxides or hydroxides.
- Ammonia or alkaline salts of phosphate, carbonate, or citrate may also be used.
- the alkaline agents can be used either separately or in combination in accordance with methods practiced by those skilled in the art.
- the alkali is added to a suspension of insoluble acid casein in water in an amount sufficient to raise the pH from the isoelectric point, pH 4.5, to between pH 6 and 8, and more generally around pH 7.
- calcium hydroxide When calcium hydroxide is used as the sole alkaline agent, the amount of calcium that needs to be added is dictated by the desired pH change and the neutralizing properties of this protein.
- calcium caseinates can be made through standard processing techniques to contain a maximum of approximately 1.4 grams of calcium per 100 grams of protein.
- An insoluble or partially soluble calcium salt is added to the above suspension or solution of protein.
- Calcium carbonate, calcium phosphate (in any of its several forms), and calcium citrate are three such salts, but this is not meant to be an all inclusive list.
- the insoluble salts should have a particle diameter in the range of 0.1 to 100 microns and preferably less than about 20 microns. Smaller particle sizes are preferred, but calcium carbonate and calcium phosphate with average particle sizes between 1 and 15 microns are suitable.
- the insoluble calcium salt can be added directly to the protein preparation in an agitated vessel, the salt can be suspended in water or other media as a slurry which is added to the protein preparation, or the salt can be added to the protein preparation through an in-line mixer or mill in either a continuous or a batch operation. Little reaction appears to take place between the insoluble calcium salt and the protein, and the insoluble calcium salt may settle rapidly out of the protein and salt mixture if the mixture is not continuously agitated.
- Other components could be added to the mixture of protein and calcium salt (for instance carbohydrates, gums, fats, emulsifiers, salts, and so forth), but these are not required for obtaining the desired effect of producing a stable suspension of the insoluble calcium salt.
- the mixture is then dried.
- the mixture would be pasteurized by heat treatment or by other means to reduce the microbial content prior to drying.
- Spray dryers of various configurations are typically used for this operation, but attrition dryers, ring dryers, belt dryers, or other pieces of equipment known by those skilled in the art could also be used.
- the dried composition can now be used in the same fashion that the individual components would have been used with the beneficial effect that reconstitution and use of this dried composition provides a calcium supplement that does not sediment or separate from high, medium, or low viscosity products.
- the advantageous suspension properties appear to be due to interactions between the insoluble calcium salt and the protein during the process of drying. During that process, the removal of water or liquid media may provide intimate contact between the components of the mixture in a way that may not be achieved by other means.
- CaCO 3 with an average particle size of 1 micron was added directly to the mix.
- the CaC0 3 could also be added by dispersing the salt in 6,000 grams of water, or added by injecting the water dispersion of the salt through a high shear mill. The mixture was then pasteurized (heated to 162°F and held for 30 minutes) and spray dried. The dried, high calcium caseinate product had a protein content of 86%o, an ash content of 8%, and a calcium content of 3.8%. The calcium to protein ratio was 0.043.
- CaCO 3 was also prepared and observed.
- the two 15 milliliter suspensions contained 0.68 grams of protein and 0.07 grams of CaCO 3 .
- the high calcium caseinate was also compared to a mix of standard caseinate and unprocessed calcium carbonate in a liquid nutritional formulation that contained a balanced amount of protein, carbohydrate, fat, and minerals.
- the ingredients used to prepare the control and the test formulations are given below.
- the test formulation was made with high calcium caseinate replacing both the standard caseinate and the calcium carbonate.
- calcium carbonate with a average particle size of 1 micron was used.
- control and the test formulations were pre ared in the same fashion, processed in the same equipment, and tested in the same manner.
- the liquid formulations were homogenized at 2000 psi, packaged in 10 ounce glass jars, and sterilized in a rotary retort. Maximum temperature was 250°F for 5 minutes. After sterilization, product characteristics were noted during six months of storage at room temperature.
- High calcium caseinate was prepared as described above (Example 1) using 1 micron particle sized calcium carbonate. To ten (10) pounds of acid casein, neutralized in the same way as in Example 1 , was added twenty-seven (27) pounds of 1 micron CaC0 3 . The mixture was pasteurized and dried as in Example 1. The dried product had a protein content of 25%, an ash content of 43%, and a calcium content of 34%>. The calcium to protein ratio was 1.36, or nearly 40 times that in milk.
- the improvement in sediment separation of the insoluble calcium salt was tested by suspending five (5) grams of the processed high calcium caseinate in 100 milliliters of water and observing the sediment compared to that of a similar composition of unprocessed sodium caseinate plus CaCO 3 .
- the two 15 milliliter suspensions contained 0.13 grams of caseinate and 0.62 grams of CaC0 3 .
- Example 2 Compared to the control of unprocessed caseinate and CaC0 3 , the high calcium caseinate of Example 2 produced less sediment over a longer period of time. It was also unexpected that a small amount of protein could improve the suspension characteristics of a relatively large amount of insoluble CaC0 3 . Because sediment was evident in the control mixture of unprocessed caseinate and calcium carbonate, the mere presence of caseinate was insufficient to produce the observed benefit.
- High calcium caseinates were prepared as described in Example 1 , but using either 1 micron, Example 3A; or 5 micron, Example 3B; or 14 micron particle sized calcium carbonate, Example 3C.
- the particle sizes provided herein are the average particle diameters reported by the supplier, ECC America, Inc., a Division of ECC International.
- the spray dried products all had similar compositions: protein was 86%, ash was 8%>, calcium was 3.8%>, and the calcium to protein ratio was 0.043.
- Improvement to sediment separation of the insoluble calcium salt was tested by suspending 0.75 grams of the dried product in 15 milliliters of water and observing and measuring the amount of sediment compared to a control suspension of unprocessed sodium caseinate mixed with the unprocessed calcium salt at the same concentrations.
- Two of the three ingredients (3 A and 3C) were used in preparing liquid formulations that contained a balanced amount of protein, carbohydrate, fat, and minerals.
- the ingredient levels used in the formulations were similar to those shown in the table of ingredients in Example 1 except that the test products were made with Examples 3A and 3C high calcium caseinates. Observations were made during storage of these formulations for up to six months.
- the formulations containing high calcium caseinates made with 1 micron (3 A) and with 14 micron (3C) average particle size calcium carbonate did not exhibit any sediment even after six months of quiescent storage while the formulation containing unprocessed, 1 micron calcium carbonate rapidly accumulated an obvious white sediment that was difficult to resuspend.
- the general appearance of the liquid was also improved when the processed high calcium caseinates (Examples 3 A and 3C) used in the formulations. They were less grainy immediately after sterilization, and remained homogeneous for a much longer time during storage than did the control product which was made using unprocessed caseinate and calcium carbonate.
- High calcium caseinate was prepared as described in Example 1 , above, but with tricalcium phosphate (Fortitech, micronized to 15 microns) as the insoluble calcium salt.
- Calcium phosphate was chosen because it is a commonly used calcium supplement and because both calcium and phosphate are complimentary parts of a balanced diet.
- the dried, high calcium caseinate product had a protein content of 86%, an ash content of 8%>, and a calcium content of 3.8%o.
- the calcium to protein ratio was 0.043.
- the sediment characteristics of the high calcium caseinate was compared to the sediment characteristics of sodium caseinate and unprocessed calcium phosphate and was compared to the high calcium caseinate of Example 3C made with 14 micron calcium carbonate.
- the unprocessed 15 micron calcium phosphate settles rapidly out of a suspension containing standard, unprocessed sodium caseinate.
- the 15 micron calcium phosphate was dried in the presence of caseinate and then reconstituted in water, the processed insoluble calcium salt remained in suspension longer than unprocessed calcium phosphate and longer than processed, insoluble calcium carbonate of approximately the same particle size.
- the calcium to protein ratio is 0.072, or twice the ratio found in milk. Improvement to sediment separation was tested by suspending 0.75 grams of the dried product in 15 milliliters of water and observing and measuring the amount of sediment compared to a control suspension of unprocessed milk protein concentrate mixed with unprocessed calcium carbonate at the same concentrations.
- TMP Total Milk Protein
- CaC0 3 calcium carbonate
- the mixture was pasteurized (heated to 160°F and held for 30 minutes) and then spray dried.
- the composition of the product was similar to that of the high calcium caseinates in Examples 1, 2, and 3.
- the powder was 86%> protein, 8% ash, and 3.8%> calcium, and the calcium to protein ratio was 0.043, the same as the caseinate examples.
- the sediment separation of the processed calcium carbonate was tested by suspending 0.75 grams of the dry powder of Example 6 in 15 milliliters of water and observing the amount of sediment.
- Example 6 Essentially no sediment was observed for the reconstituted powder of Example 6, while the control mixtures of unprocessed CaC0 3 in Examples 1, 2, and 3 showed three to ten times as much sediment.
- the types of milk protein (casein plus whey) are similar for Milk Protein Concentrate (Example 5) and for this coprecipitate (TMP, Example 6)
- the interactions between the whey and casein are different for the two protein ingredients. It is not known if the presence of whey proteins, or if the presence of soluble protein aggregates, or if completely different rationales can be used to explain the highly beneficial effects that this invention provides when insoluble calcium salts are dried in the presence of a combination of casein and whey.
- soy protein isolate (Supro 1500, Protein Technologies, International) were dispersed into 280 pounds of water at 110°F. After 15 minutes of agitation, the pH was measured at 6.8, more or less, and 1,080 grams of CaCO 3 (1 micron particles from ECC) blended with 5,000 grams of water was added to the soy isolate through a colloid mill. The mix was stirred for 15 minutes, pasteurized (heated to 162°F and held for 30 minutes), and spray dried. The composition of the product was 80%> protein, 8%> ash, and 3.7%> calcium. The calcium to protein ratio was 0.046 which is higher than the calcium to protein ratio in milk (0.035) and close to that of the high calcium caseinates of Examples 1, 2, and 3.
- Sediment separation of the calcium salt was measured by suspending 5 grams of the product of Example 7 in 100 milliliters of water and observing the sediment which collected when 15 milliliters of this preparation was allowed to sit quiescently for 12 hours.
- the high calcium soy isolate was also formulated into a beverage like that described in Example 1.
- the formulation was packaged in 10 ounce glass jars and sterilized by the retort process described in Example 1. During six months of storage, no sediment was observed.
- the high calcium proteins made via this invention retain desirable functional attributes while also providing a high level of calcium.
- the high calcium caseinates of Examples 1 through 3 are actually sodium caseinates with sodium caseinate solubility, viscosity, and emulsion stabilizing characteristics, but they also form opaque dispersions like calcium caseinate and they contain more calcium than a typical calcium caseinate made by conventional process technology.
- Example 2 shows that insoluble calcium salts can be modified to greatly improve their suspension characteristics by drying these salts in the presence of just a small amount of protein.
- the product of Example 2 could be used not only as an ingredient for making processed foods, but also as a dispersible calcium supplement for addition to prepared foods, for consumption as a compressed tablet, for supplementing confections or gums, for whitening coffee or tea, and as an anti-caking ingredient dusted onto shredded cheese.
- This high calcium, low protein product may also be useful in the paper coating, paper filling, and pigment industries where a readily dispersible, small particle sized insoluble calcium salt that does not rapidly settle out of suspension and that contains an adhesive type of protein (caseinate or soy isolate) would provide unique benefits to processing or product quality in those particular industries.
- Dairy products and analogs such as milk, shakes, yogurt, cheese and sour cream can be homogeneously supplemented with more calcium than they currently deliver.
- Drinks and dry mixes for making drinks can now be supplemented with bioavailable calcium that does not sediment or taste gritty or chalky.
- Processed meats, confections, and bakery items that typically use a protein source from soy, egg, milk or grains can now obtain the same functional attributes using a high calcium protein from the same source.
- the opacity feature of this invention might be used by these skilled in the art of providing visual appeal to low fat foods or for making a coffee whitener which delivers enough calcium to a cup of coffee to be equivalent to drinking eight ounces of milk. While the above provides a full and complete disclosure of the preferred embodiments of the invention, various modifications, alternate constructions and equivalents may be employed, as desired. Therefore, the above description and examples should not be construed as limiting the scope of the invention, which is defined by the appended claims.
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Peptides Or Proteins (AREA)
- Dairy Products (AREA)
- Processes Of Treating Macromolecular Substances (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0000119A HUP0000119A3 (en) | 1996-12-24 | 1997-12-23 | Method of suspending insoluble calcium salts in protein composition |
JP52904898A JP2001507072A (ja) | 1996-12-24 | 1997-12-23 | タンパク質組成物中に不溶性カルシウム塩類を懸濁する方法 |
EP97952612A EP0948569A1 (en) | 1996-12-24 | 1997-12-23 | Method of suspending insoluble calcium salts in protein compositon |
AU56183/98A AU728978B2 (en) | 1996-12-24 | 1997-12-23 | Method of suspending insoluble calcium salts in protein compositon |
PL97334249A PL334249A1 (en) | 1996-12-24 | 1997-12-23 | Method of producing a suspension of non-soluble calcium salts in a proteinous composition |
BR9714186-0A BR9714186A (pt) | 1996-12-24 | 1997-12-23 | Método para suspensão de sais de cálcio insolúveis em composição de proteìna |
NZ336583A NZ336583A (en) | 1996-12-24 | 1997-12-23 | Method of suspending insoluble calcium salts in protein composition by adding a protein source and heating |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/774,861 | 1996-12-24 | ||
US08/774,861 US5766330A (en) | 1996-12-24 | 1996-12-24 | Method of suspending insoluble calcium in protein composition |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1998028367A1 true WO1998028367A1 (en) | 1998-07-02 |
Family
ID=25102520
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/023785 WO1998028367A1 (en) | 1996-12-24 | 1997-12-23 | Method of suspending insoluble calcium salts in protein compositon |
Country Status (10)
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6139901A (en) * | 1997-09-16 | 2000-10-31 | New Zealand Milk Products (North Amerca) Inc. | Membrane filtered milk proteins varying in composition and functional attributes |
EP0933029A1 (en) * | 1998-02-03 | 1999-08-04 | Xyrofin Oy | Skimmed milk powder substitute |
US6007852A (en) * | 1998-04-10 | 1999-12-28 | Sargento Foods Inc. | Calcium enriched natural cheese |
AUPP494798A0 (en) | 1998-07-29 | 1998-08-20 | Pacific Biolink Pty Limited | Protective protein formulation |
GB9902670D0 (en) * | 1999-02-06 | 1999-03-31 | Nutrahealth Ltd | Calcium fortified fat product and process for the preparation thereof |
US6395198B1 (en) | 1999-10-01 | 2002-05-28 | Mcardle Biaise | Anti-caking and anti-dusting composition and corresponding methods |
JP4161031B2 (ja) * | 2000-10-31 | 2008-10-08 | 独立行政法人産業技術総合研究所 | 亜鉛含有リン酸カルシウム微粒子含有懸濁液または粒子溶媒混合系及び亜鉛欠乏症治療剤 |
US20040071789A1 (en) * | 2002-02-14 | 2004-04-15 | Baron John A | Calcium supplementation to reduce prostate cancer risk |
US6982100B2 (en) * | 2002-08-02 | 2006-01-03 | Land O'lakes, Inc. | Method for cheese manufacture |
US6902750B2 (en) * | 2002-08-02 | 2005-06-07 | Land O'lakes, Inc. | Method for the manufacture of process cheese |
EP1388297A1 (en) * | 2002-08-06 | 2004-02-11 | Nestec S.A. | Calcium absorption enhancer |
US7022355B2 (en) * | 2003-05-08 | 2006-04-04 | Solae, Llc | Composition and process for the production of a vegetable protein composition containing an alkaline earth metal salt |
US7226620B2 (en) * | 2004-05-04 | 2007-06-05 | Rhodia Inc. | Directly compressible tricalcium phosphate |
DE602004023696D1 (de) | 2004-05-12 | 2009-12-03 | Solae Llc | Zusammensetzung und Prozess zur Herstellung eines vegetarischen Proteins enthaltend ein Eralkalimetall-Salz |
CN100342795C (zh) * | 2004-05-20 | 2007-10-17 | 索莱有限责任公司 | 含有碱土金属盐的植物蛋白组合物及其制备方法 |
US20080299279A1 (en) * | 2007-06-04 | 2008-12-04 | Land O'lakes, Inc. | Calcium fortification of food powders |
NZ563962A (en) * | 2007-12-03 | 2010-09-30 | Fonterra Co Operative Group | Dairy product and process |
CN116326782A (zh) * | 2023-03-31 | 2023-06-27 | 南京北极光生物科技有限公司 | 一种蛋白钙及其制备方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2181003A (en) * | 1936-01-11 | 1939-11-21 | Borden Co | Soluble dried solids of milk and method of producing the same |
US2330428A (en) * | 1940-10-28 | 1943-09-28 | Wyandotte Chemicals Corp | Manufacture of calcium carbonateadhesive coatings |
US4126607A (en) * | 1973-01-29 | 1978-11-21 | Chelsea Industries, Inc. | Casein derivatives and method of producing the same |
US4701329A (en) * | 1986-02-10 | 1987-10-20 | Borden, Inc. | Calcium-fortified milk |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3440054A (en) * | 1964-03-05 | 1969-04-22 | Griffith Laboratories | Production of proteinates |
JPS61242562A (ja) * | 1985-04-22 | 1986-10-28 | Shokuhin Sangyo Ekusutoruujohn Kutsukingu Gijutsu Kenkyu Kumiai | 易分散性カルシウム製剤及びその製法 |
US4642238A (en) * | 1986-02-03 | 1987-02-10 | Ralston Purina Company | Process for the production of a mineral fortified protein composition |
DE69006312T2 (de) * | 1989-11-02 | 1994-05-05 | Kubota Kk | Brennkraftmaschine mit mechanischem Regler und Dekompressionsvorrichtung. |
JP2946022B2 (ja) * | 1995-07-04 | 1999-09-06 | 株式会社白石中央研究所 | 炭酸カルシウム水懸濁液組成物およびその製造方法 |
JP3613488B2 (ja) * | 1996-01-17 | 2005-01-26 | 雪印乳業株式会社 | 栄養補給用組成物 |
-
1996
- 1996-12-24 US US08/774,861 patent/US5766330A/en not_active Expired - Fee Related
-
1997
- 1997-12-23 JP JP52904898A patent/JP2001507072A/ja not_active Ceased
- 1997-12-23 WO PCT/US1997/023785 patent/WO1998028367A1/en not_active Application Discontinuation
- 1997-12-23 HU HU0000119A patent/HUP0000119A3/hu unknown
- 1997-12-23 EP EP97952612A patent/EP0948569A1/en not_active Ceased
- 1997-12-23 BR BR9714186-0A patent/BR9714186A/pt not_active Application Discontinuation
- 1997-12-23 AU AU56183/98A patent/AU728978B2/en not_active Ceased
- 1997-12-23 NZ NZ336583A patent/NZ336583A/xx unknown
- 1997-12-23 PL PL97334249A patent/PL334249A1/xx unknown
- 1997-12-23 KR KR1019997005744A patent/KR20000062314A/ko not_active Withdrawn
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2181003A (en) * | 1936-01-11 | 1939-11-21 | Borden Co | Soluble dried solids of milk and method of producing the same |
US2330428A (en) * | 1940-10-28 | 1943-09-28 | Wyandotte Chemicals Corp | Manufacture of calcium carbonateadhesive coatings |
US4126607A (en) * | 1973-01-29 | 1978-11-21 | Chelsea Industries, Inc. | Casein derivatives and method of producing the same |
US4701329A (en) * | 1986-02-10 | 1987-10-20 | Borden, Inc. | Calcium-fortified milk |
Also Published As
Publication number | Publication date |
---|---|
HUP0000119A3 (en) | 2001-02-28 |
NZ336583A (en) | 2000-10-27 |
EP0948569A1 (en) | 1999-10-13 |
AU5618398A (en) | 1998-07-17 |
EP0948569A4 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1999-11-24 |
BR9714186A (pt) | 2000-02-29 |
HUP0000119A2 (hu) | 2000-06-28 |
JP2001507072A (ja) | 2001-05-29 |
KR20000062314A (ko) | 2000-10-25 |
AU728978B2 (en) | 2001-01-25 |
US5766330A (en) | 1998-06-16 |
PL334249A1 (en) | 2000-02-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5766330A (en) | Method of suspending insoluble calcium in protein composition | |
EP0235971B1 (en) | Calcium-fortified milk | |
JP6240653B2 (ja) | 栄養素の風味をマスクするための組成物及び該組成物の調製方法 | |
RU2265338C2 (ru) | Обогащенные кальцием молоко и молочные продукты и способ их приготовления | |
JPH10262611A (ja) | 強化食品 | |
JP4484992B2 (ja) | 食品添加剤スラリー組成物及びパウダー組成物、並びにこれらを含有する食品組成物 | |
IE48398B1 (en) | A process for treating a protein source and a food product having a treated protein source prepared by the process | |
JP2002525091A (ja) | 栄養性カルシウム源が補給された低酸性飲料 | |
JPH10225263A (ja) | 鉄分を強化した発酵乳およびその製造方法 | |
EP1430792A1 (en) | Food-additive slurry composition and powder composition, and food composition containing these | |
US20060198927A1 (en) | Food additive composition, and food composition containing same | |
JP2005073695A (ja) | 高分散性乳清カルシウム組成物及びその製造方法 | |
AU2008332009A1 (en) | A method of preparing a yoghurt product which is a good source of calcium and having increased gel strength | |
JPH0856567A (ja) | カルシウム強化乳性酸性濃縮飲料及びその製造方法 | |
MXPA99005969A (en) | Method of suspending insoluble calcium salts in protein compositon | |
JPH11504201A (ja) | 粉砕卵殻で強化した乳製品 | |
JP3083579B2 (ja) | カルシウム強化飲料及びその製造法 | |
JPWO2004039178A1 (ja) | 食品添加剤組成物及びこれを含有する食品組成物 | |
JP4084524B2 (ja) | 飲料もしくはペースト状食品、及び懸濁液 | |
WO2024227514A1 (en) | Dephosphorylation of skim milk, ultra-filtered milk or micellar casein isolate | |
WO2001017375A1 (en) | Calcium fortified emulsified fat product and calcium salts | |
JPH0383564A (ja) | カルシウム補給飲料及びその製造方法 | |
JP2002065209A (ja) | 粘弾性を有する新規なカルシウム剤及びその製造方法 | |
MXPA00002452A (es) | Complejos de calcio para enriquecimiento de alimentos | |
MXPA01003252A (en) | Low acid beverages supplemented with nutritional calcium sources |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): GH GM KE LS MW SD SZ UG ZW AT BE CH DE DK ES FI FR GB GR IE IT LU |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1997952612 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 1998 529048 Country of ref document: JP Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: PA/a/1999/005969 Country of ref document: MX Ref document number: 1019997005744 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 336583 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 56183/98 Country of ref document: AU |
|
WWP | Wipo information: published in national office |
Ref document number: 1997952612 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
NENP | Non-entry into the national phase |
Ref country code: CA |
|
WWP | Wipo information: published in national office |
Ref document number: 1019997005744 Country of ref document: KR |
|
WWG | Wipo information: grant in national office |
Ref document number: 56183/98 Country of ref document: AU |
|
WWR | Wipo information: refused in national office |
Ref document number: 1997952612 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1997952612 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1019997005744 Country of ref document: KR |